Jq. Wang et al., THE MUSCARINIC TOXIN-3 AUGMENTS NEUROPEPTIDE MESSENGER-RNA IN RAT STRIATUM IN-VIVO, European journal of pharmacology, 334(1), 1997, pp. 43-47
The selective M-4 muscarinic receptor toxin, MT3, was used in vivo to
evaluate the role of M-4 receptors in cholinergic inhibition of neurop
eptide mRNA expression in striatonigral neurons. Unilateral injection
of the muscarinic toxin 3 (0.04-4 nmol) into the dorsal striatum of ch
ronically-cannulated rats elevated basal levels of preprodynorphin, su
bstance P and preproenkephalin mRNAs in the ipsilateral dorsal striatu
m as revealed by quantitative in situ hybridization. Pretreatment with
muscarinic toxin 3 also augmented amphetamine (2.5 mg/kg, i.p.)-stimu
lated preprodynorphin and substance P expression in the dorsal striatu
m in a manner similar to that observed after the muscarinic antagonist
, scopolamine. Since muscarinic toxin 3 has a much greater affinity fo
r muscarinic M, receptors than for other subtypes, it is possible that
muscarinic toxin 3, by interacting with the muscarinic M:, subtype, r
egulates basal and/or dopamine-stimulated striatal neuropeptide gene e
xpression. (C) 1997 Elsevier Science B.V.